J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 1, 2004

Papers In Press, published online ahead of print October 16, 2003
J. Lipid Res., doi:10.1194/jlr.M300214-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M300214-JLR200v1
45/1/124    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cianflone, K.
Right arrow Articles by Sniderman, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cianflone, K.
Right arrow Articles by Sniderman, A. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on May 22, 2003
Revised on September 30, 2003
Accepted on October 8, 2003

Fasting acylation stimulating protein is predictive of postprandial triglyceride clearance

Katherine Cianflone, Robert Zakarian, Charles Couillard, Bernadette Delplanque, Jean-Pierre Despres, and Allan D. Sniderman

Medicine, Division of Cardiology, Mike Rosenbloom Laborabory for Cardiovascular Research, McGill University Health Centre, Montreal, Quebec H3A 1A1

Corresponding Author: Katherine.Cianflone{at}mcgill.ca

The aim of the present study was to compare plasma triglyceride (TG) and non-esterified fatty acid (NEFA) clearance in normals stratified by plasma ASP and gender to determine the contribution of fasting ASP. A healthy normal population of 70 men and 71 women was tested for postprandial responses to a high fat mixed meal. Subjects were divided into three tertiles, according to fasting ASP. In the highest ASP tertile only, there was a significant decrease in plasma ASP over the 8 hours (909.7 nM to 705.9 nM, p<0.05 males and 61.94.0 nM to 45.66.2 nM, p<0.01 females). Postprandial TG was progressively delayed from lowest to highest ASP tertile, (p<0.0001, 2-way ANOVA, both genders), with the greatest differences in males. In both men and women, fasting ASP correlated positively with postprandial TG response. Postprandial NEFA increased over 8 hours and progressively increased from lowest to highest ASP tertile, with more pronounced changes in males than females. Stepwise-multiple-regression determined that the best prediction of postprandial TG was: [fasting ASP + apolipoprotein B + insulin + TG; r = 0.806] for men and [fasting ASP + total cholesterol; r = 0.574] for women. In neither gender did leptin, BMI or any other fasting variables improve the prediction. Thus in men and women, ASP significantly predicted postprandial TG and NEFA clearance, both of which were significantly more rapid in women compared to men. Fatty acid trapping appeared to be more rapid in women than in men and based on their lower plasma ASP levels, women may be more ASP sensitive than men. Plasma ASP may be useful as a fasting variable that will provide additional information regarding postprandial TG and NEFA clearance.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Paglialunga, A. Fisette, Y. Yan, Y. Deshaies, J.-F. Brouillette, M. Pekna, and K. Cianflone
Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice
Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E521 - E529.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. Cui, S. Paglialunga, D. Kalant, H. Lu, C. Roy, M. Laplante, Y. Deshaies, and K. Cianflone
Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1482 - E1491.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Marcil, H. Vu, W. Cui, Z. Dastani, J. C. Engert, D. Gaudet, M. Castro-Cabezas, A. D. Sniderman, J. Genest Jr, and K. Cianflone
Identification of a Novel C5L2 Variant (S323I) in a French Canadian Family With Familial Combined Hyperlipemia
Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1619 - 1625.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Maslowska, H. Legakis, F. Assadi, and K. Cianflone
Targeting the signaling pathway of acylation stimulating protein
J. Lipid Res., March 1, 2006; 47(3): 643 - 652.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.